1
Clinical Trials associated with GR-1014A randomized, double-blind, vehicle-controlled, multi-centre, parallel-group study to investigate the safety, tolerability, and efficacy of GR1014 cutaneous gel as a topical radioprotector in the prevention of the radiodermatitis occurring with adjuvant radiotherapy for localized breast cancer after lumpectomy - GRA.05.SPR.0001
Start Date26 Jul 2024 |
Sponsor / Collaborator- |
100 Clinical Results associated with GR-1014
100 Translational Medicine associated with GR-1014
100 Patents (Medical) associated with GR-1014
100 Deals associated with GR-1014